# Andexanet Alfa: First Global Approval

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/andexanet-alfa-first-global-approval/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Young‐A Heo |
| Citations | 120 |
| DOI | 10.1007/s40265-018-0940-4 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://link.springer.com/content/pdf/10.1007/s40265-018-0940-4.pdf |
| OpenAlex ID | https://openalex.org/W2808991435 |
| PMID | 29926311 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Young‐A Heo](https://scholariq.org/researchers/young-a-heo/)

## Paper journal

- [Drugs](https://scholariq.org/journals/drugs/)

## Paper primary topic

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)

## Paper topics

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Venous Thromboembolism Diagnosis and Management](https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management/)
- [Cardiac Arrhythmias and Treatments](https://scholariq.org/topics/cardiac-arrhythmias-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.